• Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald

    Source: Buzz FX / 06 Mar 2025 08:32:12   America/New_York


    Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald Written by MarketBeat March 6, 2025 Share Link copied to clipboard. Aclaris Therapeutics ( NASDAQ:ACRS - Get Free Report ) was upgraded by analysts at Ca
    Read more...
Share on,